Enjoy complimentary customisation on priority with our Enterprise License!
Report on How AI is Driving Market TransformationThe menstrual drugs market size is forecast to increase by USD 3.62 billion at a CAGR of 7.75% between 2023 and 2028. The market is experiencing significant growth, driven by several key factors. Firstly, there is a growing emphasis on educating women about menstrual health and hygiene, leading to an increase in the demand for menstrual drugs. Secondly, drug therapy, such as hormonal contraceptives and menstrual suppression, is becoming increasingly popular due to their convenience and effectiveness in managing menstrual cycles. Lastly, non-drug alternatives, including herbal remedies and menstrual cups, are gaining popularity as more women seek natural and eco-friendly options. These trends are expected to continue, driving market growth and innovation in the menstrual drugs industry. The market report forecast market size, historical data spanning from 2018 - 2022, and future projections, all presented in terms of value in USD million for each of the mentioned segments.
The market report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The hormonal treatments segment is estimated to witness significant growth during the forecast period. The menstrual drugs market encompasses various treatments for Primary Dysmenorrhea and Secondary Dysmenorrhea, two types of menstrual pain. Treatment types range from medication, therapy, and surgery. Medications include analgesics for pain relief, available in various modes of administration such as oral, parenteral, and topical. Therapies like ultrasound, laparoscopy, and CT scan are used for diagnosis and treatment. Diagnosis methods include pelvic examinations, imaging techniques, and hormonal tests. Dysmenorrhea patient epidemiology is increasing due to various factors, leading to a growing demand for menstrual drugs.
Get a glance at the market share of various regions Download the PDF Sample
The hormonal treatments segment accounted for USD 1.46 billion in 2018. The pipeline analysis includes emerging treatments like gene therapy and digital health solutions, including telemedicine. Healthcare infrastructure includes hospitals, specialty clinics, homecare, hospital pharmacy, retail pharmacy, and online pharmacy as distribution channels. Combined oral contraceptives are commonly prescribed for menstrual pain relief. Treatment duration and side effects vary depending on the medication and patient condition. Clinical trials are underway in Phase 2 for new treatments for heavy menstrual bleeding. Side effects of menstrual drugs include nausea, vomiting, headache, and allergic reactions. Healthcare providers prescribe medications based on the patient's medical history, age, and other factors. Menstrual drugs market growth is influenced by increasing awareness, improving healthcare infrastructure, and technological advancements.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 33% to the growth of the global market during the market forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The Menstrual Drugs Market comprises a range of treatments for menstrual cramps and menstrual hygiene. Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies distribute these drugs. Alternative treatments, such as the Livia Portable Device using SmartWave Technology, also gain popularity. Medical Reimbursement plays a significant role in the market, making prescription treatments more accessible. Prostaglandins, Non-steroidal anti-inflammatory drugs (NSAIDs) like Ibuprofen and Naproxen sodium, and Hormonal therapy are common treatments for menstrual cramps. These drugs are available in various forms, including tablets, capsules, and topical applications. Drug stores and Online providers stock a wide range of these treatments. Menstrual Hygiene Day, an annual global event, emphasizes the importance of good menstrual hygiene. It's crucial to maintain cleanliness during menstruation to prevent infections. Menstrual Hygiene Day also raises awareness about the availability of various treatments for menstrual cramps. The Menstrual Treatment market continues to grow, driven by the increasing demand for effective pain relief and menstrual hygiene solutions. Consumers' preference for convenient, accessible, and affordable treatments, such as over-the-counter NSAIDs, further propels the market's growth.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The market encompasses various treatments for Menstrual Cramps, specifically Primary Dysmenorrhea and Secondary Dysmenorrhea. The Treatment Type for Menstrual Cramps includes Medication, Therapy, Surgery, and Diagnosis, ultrasound, Laparoscopy, and CT scan are common Diagnosis methods. The Mode of Prescription can be Oral Administration, Injectable Administration, or Topical Administration. Menstrual cramps, also known as Dysmenorrhea, can cause Pelvic Pain and Heavy Menstrual Bleeding. Treatment for Menstrual Cramps includes Analgesics like Prostaglandins, Non-steroidal anti-inflammatory drugs (NSAIDs) such as Ibuprofen and Naproxen sodium, and Hormonal therapy. Over-the-counter medicines are also available for self-treatment. The Menstrual Cramps Treatment market is expanding due to the increasing number of women suffering from Menstrual Cramps, especially those with Endometriosis. Clinical Trials, including Phase 2, are ongoing to develop new and effective treatments. The Treatment Duration and Treatment Type can vary depending on the severity of the condition and individual response to treatment. In summary, the Menstrual Drugs Market offers various Treatment Options for Menstrual Cramps, including Medication, Therapy, and Surgery, to alleviate Pelvic Pain and Heavy Menstrual Bleeding. The market is expected to grow due to the increasing prevalence of Menstrual Cramps and ongoing research and development efforts.
The growing emphasis on educating women about menstrual health is notably driving market growth. The market has experienced significant growth due to the increasing awareness and education surrounding menstrual health. This emphasis on education empowers women to identify menstrual disorders at an early stage, leading to timely diagnosis and appropriate treatment. Two common menstrual disorders are Primary Dysmenorrhea and Secondary Dysmenorrhea, which can cause pelvic pain and heavy menstrual bleeding. Treatment types for menstrual disorders include medication, therapy, and surgery. Medications like Analgesics, Combined Oral Contraceptives, and Hormonal agents are commonly prescribed for pain relief and regulation of menstrual cycles. Therapies such as acupuncture and transcutaneous electrical nerve stimulation (TENS) are also used for pain management. Surgery, including laparoscopy and hysterectomy, is considered when other treatments are ineffective. Diagnosis of menstrual disorders involves various diagnostic tools such as ultrasound, CT scan, and laparoscopy. The mode of prescription can vary, with some medications available over the counter while others require a prescription. Treatment durations and administration modes include oral, parenteral, and topical administration.
Further, the market caters to various healthcare settings, including hospitals, specialty clinics, homecare, hospital pharmacy, retail pharmacy, and online pharmacy. The patient epidemiology for menstrual disorders is substantial, with a growing pipeline analysis for new treatments, including gene therapy and digital health solutions like telemedicine. However, it is essential to consider potential side effects when selecting a treatment option. In conclusion, the Menstrual Drugs Market is a dynamic and evolving industry, driven by the increasing awareness and education surrounding menstrual health. Early diagnosis and appropriate treatment of menstrual disorders, such as Primary Dysmenorrhea and Secondary Dysmenorrhea, are crucial for improving women's overall health and well-being. With various treatment options available, including medication, therapy, and surgery, and advancements in healthcare infrastructure, the market is poised for continued growth. Thus, such factors are driving the growth of the market during the forecast period.
The increase in popularity of drug therapy is the key trend in the market. The global market has witnessed significant growth due to the development of innovative drug therapies for managing various menstrual-related conditions. Primary and secondary dysmenorrhea, pelvic pain, endometriosis, and heavy menstrual bleeding are some of the common menstrual disorders that are addressed through pharmaceutical interventions. Treatment types include medication, therapy, and surgery, with medication being the most common mode of prescription. Medications for menstrual disorders come in various forms such as oral, parenteral, implants, and topical administration. Analgesics, combined oral contraceptives, and hormonal therapies are commonly used for managing dysmenorrhea and pelvic pain.
Also, clinical trials in phase 2 are ongoing for new treatment modalities like gene therapy and digital health solutions, including telemedicine, to improve patient access and convenience. Diagnostic tools like ultrasound, CT scan, and laparoscopy are essential for accurate diagnosis, while hospitals, specialty clinics, homecare, hospital pharmacy, retail pharmacy, and online pharmacy channels facilitate medication distribution. Patient epidemiology and pipeline analysis indicate a growing need for effective menstrual health solutions, with side effects being a significant concern for patients. Innovative drug therapies, such as Myfembree, a once-daily treatment for managing moderate to severe pelvic pain associated with endometriosis, have received US FDA approval, highlighting the ongoing investment in research and development. Healthcare infrastructure and patient awareness are crucial factors driving the growth of the menstrual drugs market. Thus, such trends will shape the growth of the market during the forecast period.
The increasing popularity of non-drug alternatives is the major challenge that affects the growth of the market. The market encompasses a range of treatments for Primary Dysmenorrhea and Secondary Dysmenorrhea, two types of menstrual pain. Treatment types include medication, therapy, and surgery. Diagnostic tools such as ultrasound, laparoscopy, and CT scans aid in diagnosis. Medications for menstrual pain relief come in various modes of prescription, including over-the-counter, prescription, oral, parenteral, implants, and topical administration. Hospitals, specialty clinics, homecare, hospital pharmacies, retail pharmacies, and online pharmacies are common channels for procuring menstrual drugs. Patient epidemiology for menstrual disorders is significant, with an increasing number of clinical trials in Phase 2 exploring new treatment options.
Moreover, gene therapy and digital health, including telemedicine, are emerging areas of interest. Side effects are a concern for some patients, leading to a shift towards combined oral contraceptives and other non-pharmacological methods for managing menstrual symptoms. Healthcare infrastructure development and pelvic pain conditions like endometriosis further influence market growth. The treatment duration and administration mode vary depending on the specific condition and patient response. Analgesics, oral administration, and injectable administration are common methods for managing menstrual pain. Hence, the above factors will impede the growth of the market during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
AbbVie Inc. - The company offers menstrual drug namely elagolix to manage moderate to severe pain associated with endometriosis.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is witnessing significant growth due to the increasing prevalence of Primary Dysmenorrhea and Secondary Dysmenorrhea. These conditions cause severe menstrual cramps and pelvic pain, leading to the demand for effective treatments. The market offers various Treatment Types, including Medication and Therapy. Medications include Analgesics, available in different modes of administration such as Oral, Parenteral, and Topical. Combined Oral Contraceptives are also used to manage menstrual pain. Surgeries like Laparoscopy and Hysterectomy are used in severe cases. Diagnosis of Dysmenorrhea involves Ultrasound, CT scan, and Laparoscopy. The mode of prescription includes Over the Counter (OTC) and Prescription. The distribution channels include Hospitals, Specialty Clinics, Homecare, Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Pipeline Analysis reveals the presence of Gene Therapy and Digital Health solutions, including Telemedicine, in the Menstrual Drugs Market. Side Effects are a concern for some medications, leading to the exploration of alternative treatments. The market is also influenced by factors like Patient Epidemiology, Healthcare Infrastructure, and Clinical Trial Phases. Heavy Menstrual Bleeding and Endometriosis are other conditions treated with menstrual drugs. The Treatment Duration varies depending on the condition and the chosen therapy. In conclusion, the market is a dynamic and evolving industry, offering various treatment options and distribution channels for managing menstrual conditions.
Market Scope |
|
Report Coverage |
Details |
Page number |
220 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.75% |
Market growth 2024-2028 |
USD 3.62 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
7.31 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 33% |
Key countries |
US, China, Germany, India, UK, France, Japan, Canada, South Korea, and Brazil |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AbbVie Inc., Adorefem, Bayer AG, Cipla Inc., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Haleon Plc, Himalaya Wellness Co., Johnson and Johnson Services Inc., Leeford Healthcare Ltd., Mallinckrodt Plc, Maxwellia Ltd., Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi SA, SteriMax Inc., Sumitomo Chemical Co. Ltd., Teva Pharmaceutical Industries Ltd., Walgreens Boots Alliance Inc., and Zydus Lifesciences Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Technavio Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by Route of Administration
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
With the growing adoption of AI across industries, Technavio has analyzed its impact on global menstrual drugs market significant advancements in 2024, driven by the integration of Artificial Intelligence (AI). AI is playing a transformative role in enhancing drug development, optimizing supply chain management, personalizing patient care, and improving market analytics. This analysis delves into AI's impact on the Menstrual Drugs market, backed by data and real-world examples.
These insights, available exclusively through Technavio, provide an unparalleled significant impact of AI on the Menstrual Drugs market, backed by real-world examples and data.
The report provides details of AI's impact on various segment
Learn more about how AI is transforming Menstrual Drugs Market - Buy Full Report Now
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.